Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: Lucretius who wrote (224894)	3/3/2003 10:07:36 AM
From: MythMan	Read Replies (1) \| Respond to of 436258

>>9:33AM Merck: SG Cowen makes trading call (MRK) 53.45 +0.70: SG Cowen recommends purchase of stock for trading-oriented accounts in anticipation of this week's newsflow. Specifically, firm expects stock to react favorably to two events on March 4. First is closing of tender offer for Banyu acquisition (should be accretive by $0.03 and it strengthens co's position in Japan). Firm also expects positive FDA advisory review for Emend (treats nausea and vomiting post chemotherapy) as an add-on to standard therapy. << WTF?